Adaptimmune Annual report pursuant to Section 13 and 15(d)

Accrued expenses and other current liabilities (Tables)

12 Months Ended

Dec. 31, 2016

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31, 2016		December 31, 2015		June 30, 2015

Accrued clinical and development expenses	$	4,938	$	3,143	$	1,790
Accrued employee compensation and benefits payable	4,539		2,748		248
Accrued capital expenditure	3,954		42		973
Value added tax	2,014		744		—
Other accrued purchases	1,003		841		826
Other current liabilities	1,080		—		40

	$	17,528	$	7,518	$	3,877